Dave Kille

Dave Kille

Corporate Controller

Bringing Clarity to Financial Complexities.

With more than 15 years of operational experience, Dave brings to Safeguard a strong foundation in budgeting and forecasting, SEC reporting, consolidations and financial controls.

At Safeguard, Dave leads the overall accounting and reporting function while also serving as the relationship manager with all of Safeguard’s partner company finance departments.

Prior to joining Safeguard, Dave was Senior Director, Finance and Controller at Discovery Laboratories, a publicly-traded biotechnology company focused on developing surfactant therapies for respiratory diseases, where he was responsible for forecasting and budgeting, SEC reporting and financial controls. In addition, Dave built financial capabilities for the commercial launch of the Company’s first FDA-approved product, and prepared financial models for company valuations, potential strategic alliances and product licensing opportunities.

Dave was Manager, Financial Reporting and Consolidations at Globus Medical from 2010 to 2012 where he was responsible for financial reporting and analysis, global consolidations and drafting of the financial sections of the Form S-1 filed with the SEC in connection with the Company’s IPO in 2012.

Dave began his career at Ernst & Young as a Senior Auditor. Dave is a Certified Public Accountant and has a B.S. in Accounting from Penn State University.

"From due diligence to revenue recognition, the team at Safeguard helps our partner companies develop and execute successful business models. When you become a Safeguard partner company, you’re able to leverage the efficiencies of Safeguard’s operational platform and realize better results when faced with various challenges and opportunities."

March 7, 2017

Winning the Digital Disruption Game: Answering the ‘CAST’ing Call

This post originally appeared on CIOReview.com on March 6th, 2017.  By: Peter Coffee, VP for Strategic Research, Salesforce and Scott Snyder, Chief Technology and Innovation Officer,…


February 7, 2017

Outside of the Valley, Alternative Markets Attract Investors

Nearly 60 percent of all U.S. venture capital activity is concentrated in the Bay Area, Boston metro, and New York City’s orbit.[1] For some entrepreneurs,…

Cybersecurity Medical Devices

January 26, 2017

Commentary: Postmarket Management of Cybersecurity in Medical Devices

Over the last 18 months, an alarming number of medical device companies’ challenges with data security have been exposed. In 2015, Hospira’s LifeCare PCA3 and…